Home » Newsletters » BioWorld Science

BioWorld Science

March 22, 2000

View Archived Issues

Chrysalin accelerates fracture healing in preclinical animal studies

Dermagraft epicardial patch induces angiogenesis in preclinical studies

Alliance makes progress in phase II/III LiquiVent trial

Oral Hectorol clinical progress updated

StressGen initiates phase II study with HspE7 in high-grade cervical dysplasia

Pharmadigm reports phase II results for DHEAS in burn patients

Phase I study of AltaRex's BrevaRex MAb completed

Dura enters definitive merger agreement to acquire Spiros

Norditropin SimpleXx approved in Japan

Drug notification issued for Pulmozyme due to packaging defect

Val-HeFT study to investigate benefits of Diovan in heart failure

New ADIR compounds particularly useful for solid tumors

AstraZeneca synthesizes amide derivatives as cytokine production inhibitors

SB adds another anticonvulsant series to its pipeline

Spanish lab describes early research results in the area of COX-2 inhibitors

Lilly presents another series of indole sPLA2 inhibitors

Novel lactams prepared at DuPont inhibit Abeta-peptide production

Known antiallergic agent from Kyorin now claimed for use in MS

Gallic acid induces oxidation-dependent apoptosis in human lung cancer cells

Ferriprox launched in Europe

Antiproliferative and apoptosis-inducing effects of NS-398

Coreg trial stopped early due to positive results

Shionogi's TxA2 receptor antagonist inactive in model of silica-induced lung fibrosis

Effects of TAK-603 on cytokine production reported at Japanese congress

Warner-Lambert discontinues sale of Rezulin

Magainin A: rabbit studies suggest its promise as a vaginal contraceptive

Early clinical results presented for SB-242235 at scientific meeting

Comparative studies with Hoe-901 and other insulins reported at ASCPT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...